Description

Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.

Figure 2

Chart

Source Paper

Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Prevention of Antibiotic Associated Diarrhea and Clostridium difficile.

Nutrients (2018)

PMID: 29701662

DOI: 10.3390/nu10050539

Cite This Figure

![Figure 2: Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.]()

> Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." *Nutrients*, 2018. PMID: [29701662](https://pubmed.ncbi.nlm.nih.gov/29701662/)

<figure>
  <img src="" alt="Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period." />
  <figcaption>Figure 2. Antibiotic-associated diarrhea incidence in ICU patients receiving the Lactobacillus casei probiotic drink versus standard care is compared over the intervention period.<br>  Source: Cathy Alberda et al. "Feasibility of a Lactobacillus casei Drink in the Intensive Care Unit for Preven." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/29701662/">29701662</a></figcaption>
</figure>

Related Evidence

Lactobacillus casei for Antibiotic-Associated Diarrhea (AAD)

Grade C · 3 studies